Cargando…
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
The Ebola virus (EBOV) is still highly infectious and causes severe hemorrhagic fevers in primates. However, there are no regulatorily approved drugs against the Ebola virus disease (EVD). The highly virulent and lethal nature of EVD highlights the need to develop therapeutic agents. Viral protein 4...
Autores principales: | Broni, Emmanuel, Ashley, Carolyn, Adams, Joseph, Manu, Hammond, Aikins, Ebenezer, Okom, Mary, Miller, Whelton A., Wilson, Michael D., Kwofie, Samuel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094735/ https://www.ncbi.nlm.nih.gov/pubmed/37047270 http://dx.doi.org/10.3390/ijms24076298 |
Ejemplares similares
-
Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
por: Darko, Louis K. S., et al.
Publicado: (2021) -
A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani
por: Broni, Emmanuel, et al.
Publicado: (2021) -
Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin
por: Kwofie, Samuel K., et al.
Publicado: (2021) -
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery
por: Kwofie, Samuel K., et al.
Publicado: (2023) -
Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase
por: Sakyi, Patrick O., et al.
Publicado: (2022)